Elutia

NEWS

Business

Aziyo Biologics Banks Some Cash And Former Osiris Exec As Its New CEO

June 15, 2017

·

1 min read

IN THE PRESS

Press Releases

Elutia Announces Fourth Quarter and Full Year 2024 Financial Results: Strong Demand for EluPro™ in Pilot Launch Sets the Stage for Full Commercial Roll-Out

March 7, 2025

·

14 min read

Press Releases

Elutia to Report Fourth Quarter and Full Year 2024 Financial Results on Thursday, March 6, 2025

February 21, 2025

·

1 min read

Press Releases

Elutia Awarded Cardiac Rhythm Management Devices Agreement with Premier, Inc.

December 2, 2024

·

5 min read

Press Releases

Elutia Announces Strong Third Quarter Results, Accelerating Toward Full Launch of EluPro® Antibiotic-Eluting BioEnvelope in 2025

November 15, 2024

·

14 min read

Press Releases

Elutia to Report Third Quarter 2024 Financial Results on Thursday, November 14, 2024

October 30, 2024

·

1 min read

Business

Elutia Announces New Peer Reviewed Publication Highlighting the Robustness of EluPro™, Company’s Antibiotic-Eluting BioEnvelope for Implantable Devices

September 18, 2024

·

6 min read

News

Elutia Announces First Patient Implant of EluPro™, the World’s First Drug-Eluting BioEnvelope for Cardiac Pacemakers and Neurostimulators

September 5, 2024

·

6 min read

Press Releases

Elutia to Participate in Upcoming Investor Conferences

September 4, 2024

·

1 min read

Press Releases

Elutia Announces Second Quarter 2024 Results

August 8, 2024

·

14 min read

Press Releases

Elutia Appoints Ryan Marques, Ph.D., MBA as Vice President of Operations

August 1, 2024

·

2 min read

JOBS